Next Article in Journal
Delivering Two Tumour Antigens Survivin and Mucin-1 on Virus-Like Particles Enhances Anti-Tumour Immune Responses
Next Article in Special Issue
Healthcare Workers’ Perspectives on the Upcoming COVID-19 Vaccine in Terms of Their Exposure to the Influenza Vaccine in Riyadh, Saudi Arabia: A Cross-Sectional Study
Previous Article in Journal
Better Pandemic Influenza Preparedness through Adjuvant Technology Transfer: Challenges and Lessons Learned
Previous Article in Special Issue
Expanding COVID-19 Vaccine Availability: Role for Combined Orthogonal Serology Testing (COST)
 
 
Article

Article Versions Notes

Vaccines 2021, 9(5), 462; https://doi.org/10.3390/vaccines9050462
Action Date Notes Link
article xml file uploaded 6 May 2021 05:50 CEST Original file -
article xml uploaded. 6 May 2021 05:50 CEST Update https://www.mdpi.com/2076-393X/9/5/462/xml
article pdf uploaded. 6 May 2021 05:50 CEST Version of Record https://www.mdpi.com/2076-393X/9/5/462/pdf
article html file updated 6 May 2021 05:52 CEST Original file -
article html file updated 26 July 2022 18:14 CEST Update https://www.mdpi.com/2076-393X/9/5/462/html
Back to TopTop